VR Logo

Century Therapeutics Inc. (IPSC) download report


Healthcare | Biotechnology & Pharma Research

Century Therapeutics Inc. (IPSC) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies.

IPO Date: 18-Jun-2021

Pres, CEO & Director: Dr. Osvaldo Flores Ph.D.

Chief Operations Officer: Dr. Adrienne Farid Ph.D.

Listing: NASDAQ: IPSC

Country: United States

Headquarters: Philadelphia, PA

Website: https://www.centurytx.com

Key Facts

Market cap: $552.02 Mln

Revenue (TTM): $1.06 Mln

Earnings (TTM): $-114.99 Mln

Cash: $361.02 Mln

Total Debt: $25.04 Mln

Insider's Holding: 36.59%

Liquidity: Low

52 Week range: $7.32 - 32.90

Shares outstanding: 58,850,300

7 Years Aggregate:

  • CFO: $-42.14 Mln
  • EBITDA: $-160.53 Mln
  • Net Profit: $-394.17 Mln

Stock Performance

Time Period Century Therapeutics (IPSC) S&P BSE Sensex S&P Small-Cap 600
YTD-42.75-9.49-17.79
1 month2.48-2.87-2.72
3 months-28.73-8.59-12.17
1 Year-64.450.81-15.82
3 Years--10.397.14
5 Years--11.116.20
10 Years--12.0010.33
As on 24-Jun-2022